NCT04860635View on ClinicalTrials.gov

Safety of F14 Following Total Knee Replacement

PHASE2/PHASE3SuspendedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Analgesia
Interventions
DRUG

F14 (sustained release celecoxib)

Celecoxib in BEPO® drug delivery system

Trial Locations (2)

78229

Endeavor Clinical Trials, San Antonio

80401

Panorama Orthopedics & Spine Center, Denver

Sponsors
All Listed Sponsors
lead

Arthritis Innovation Corporation

INDUSTRY